The Net Margin of abrdn Life Sciences Investors (HQL) is 2135.68%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-09-30 | 2135.68% |
| 2023-09-30 | 638.85% |
| 2022-09-30 | -3463.58% |
| 2021-09-30 | 2817.90% |
| 2020-09-30 | 3629.79% |
| 2019-09-30 | -2888.52% |
| 2018-09-30 | 1440.20% |
| 2017-09-30 | 4080.95% |
| 2016-09-30 | -827.08% |
| 2015-09-30 | 3068.18% |